The U.S. Supreme Court restricted the ability of companies to patent human genetic sequences, issuing a mixed ruling in a case that raised questions about thousands of biotechnology, agricultural and drug patents.
Monsanto Co. and Dow Chemical Co. face delays in selling crops engineered to survive older weedkillers after the the U.S. Department of Agriculture announced increased scrutiny of the genetically modified plants.
Inside an industrial warehouse in South San Francisco, California, Harrison Dillon , chief technology officer of startup Solazyme Inc., examines a beaker filled with a brown paste made of sugar cane waste. While the smell brings to mind molasses, this goo, called bagasse, won’t find its way into people-pleasing confections.
Congressional talks to renew the fees drugmakers pay to fund Food and Drug Administration reviews include proposals to fast-track evaluations of medicines for conditions with no approved cures, according to two U.S. Senate aides.